Document is current
Any future updates will be listed below
-
Authors
Tuersun, Ruzeguli
Abudouwayiti, Aihaidan
Li, Yan Xiao
Pan, Ying
Aimaier, Salamaiti
Wen, Zhi-Ying
Gao, Wei-Tong
Ma, Li-Juan
Mahemuti, Ailiman
Zheng, Ying-Ying
-
Funding
Funding for this research was provided by:
The Open Research Topics for the 2023 Provincial and Ministerial Jointly-Constructed State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia (No.SKL-HIDCA-2023-4)
The Key Project of the Natural Science Foundation of Xinjiang Uygur Autonomous Region (2021D01D17)
the Xinjiang Autonomous Region Science and Technology Outstanding Youth Foundation Project (2022D01E70)
- License Information
-
More Information
Article History
Received: 8 February 2025
Accepted: 18 March 2025
First Online: 27 March 2025
Declarations
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University. The protocol was registered on ClinicalTrials.gov (identifier: NCT06092658) on October 19, 2023, and adhered to the ethical standards of the Declaration of Helsinki and national guidelines.
: Not Applicable.
: The authors declare no competing interests.
: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
